Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells
Open accessThe DOI matches its Crossref record; 63 of the 72 references it cites were found in a registry or an index.
Abstract
The neu/HER-2 proto-oncogene (also called erbB-2) encodes a transmembrane glycoprotein related to the epidermal growth factor receptor. We have purified to homogeneity a 44 kd glycoprotein from the medium of ras-transformed cells that stimulates phosphorylation of the Neu protein and retains activity after elution from the polyacrylamide gel. The protein is active at picomolar concentrations and displays a novel N-terminal sequence. Cross-linking experiments with radiolabeled p44 result in specific labeling of Neu, indicating that p44 is a ligand for Neu or a related receptor. The purified protein induces phenotypic differentiation of cultured human breast cancer cells, including altered morphology and synthesis of milk components. This is accompanied by an increase in nuclear area, inhibition of cell growth (probably by cell cycle arrest at the late S or the G2/M phases), and induction of DNA polyploidy. We propose the name Neu differentiation factor (NDF) for p44.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the 13 known ErbB ligands, EGF and heregulin (HRG) were implemented as being representative of two major specificity classes: EGF binds only ErbB1-containing dimers, and HRG binds only ErbB3- and ErbB4-containing dimers (Berkers et al, 1991; Peles, 1992; Carraway et al, 1994).”
From Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data (2009) · cites this paper as Peles, 1992
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 2×
“An association between gene amplification and overexpression and clinical outcome has been reported in breast and ovarian cancers (Slamon et al., 1987; Varley et al., 1987; Venter et al., 1987; Zhou et al., 1987; Berger et al., 1988; Tsuda et al., 1989; Slamon et al., 1989).”
BackgroundStudies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816 · cited 1×
“An association between gene amplification and overexpression and clinical outcome has been reported in breast and ovarian cancers (Slamon et al., 1987; Varley et al., 1987; Venter et al., 1987; Zhou et al., 1987; Berger et al., 1988; Tsuda et al., 1989; Slamon et al., 1989).”
BackgroundSignal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Bolton, A. E., & Hunter, W. M. (1973) · Biochemical Journal · doi:10.1042/bj1330529 · Cited by 3,254 · cited 2×
“The isolated p44 was radiolabeled with lz51 by mild reaction with the amino group-specific Bolton-Hunter reagent (Bolton and Hunter, 1973).”
MethodInfluentialThe Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015 · cited 1×
“However, unlike other growth inhibitory factors that usually act by lengthening or arresting the Gl phase (reviewed in Massague, 1990) NDF appears to restrict the completion of mitosis.”
BackgroundTumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 2×
“Cell Culture SIX Rat1 EJ cell lines were generated by transfection of the human EJ gene (an activated Harvey ras gene) into Rat1 fibroblasts as described previously (Land et al., 1983).”
BackgroundMethodGROWTH FACTOR RECEPTOR TYROSINE KINASES
Yarden, Y., & Ullrich, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002303 · Cited by 1,838
Self-citationCoussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,814 · cited 1×
“The full-length gene codes for a transmembrane tyrosine kinase that shows extensive structural homologies with receptors for growth factors and particularly the EGF receptor (Coussens et al., 1985; Bargmann et al., 1986a; Yamamotoet al., 1986).”
BackgroundCarpenter, G., & Cohen, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38983-5 · Cited by 1,622
The trk proto-oncogene encodes a receptor for nerve growth factor
Klein, R., Jing, S., Nanduri, V., O'Rourke, E., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90419-y · Cited by 1,401 · cited 1×
“However, some of these receptors can also transmit differentiation signals, as exemplified by the receptors for the nerve growth factor (Kaplan et al., 1991; Klein et al., 1991) and the fibroblast growth factors (reviewed by Rifkin and Moscatelli, 1989).”
Background
Cited by
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Requirement for neuregulin receptor erbB2 in neural and cardiac development
Lee, K.-F., Simon, H., Chen, H., Bates, B., Hung, M.-C., & Hauser, C. (1995) · Nature · doi:10.1038/378394a0 · Cited by 1,290
Neuregulins: functions, forms, and signaling strategies
Falls, D. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00102-7 · Cited by 1,071
“heregulin (HRG [2]), neu differentiation factor (NDF [3,4]), and sensory and motor neuron-derived factor (SMDF [35]), —cannot be taken to indicate specific biological functions of the isoforms to which these names have been applied.”
BackgroundInfluentialThe ERBB network: at last, cancer therapy meets systems biology
Yarden, Y., & Pines, G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3309 · Cited by 988
Self-citationNeuregulin 1 in neural development, synaptic plasticity and schizophrenia
Mei, L., & Xiong, W.-C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2392 · Cited by 1,030
Metadata
- Authors
- Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B., & Yarden, Y.
- Affiliations
- Weizmann Institute of Science (IL)
- Amgen (United States) (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1992-04
- Volume
- 69
- Issue
- 1
- Pages
- 205-216
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2043471865
- Cited by
- 524
- References
- 72
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2022: 3 · 2020: 6 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 3 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 8
- FWCI
- 25.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Israel Cancer Research Fund
- Israel Academy of Sciences and Humanities
- National Institutes of Health (5r01ca051712-06)
- National Cancer Institute (CA 51712, CA-50843)
- Topics
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- ERBB2, ligand isolation, receptor tyrosine kinase, breast cancer cells, Ras-transformed cells, cell cycle arrest, neu differentiation factor
- MeSH terms
- Proto-Oncogene Mas, Amino Acid Sequence, Animals, Cell Differentiation, Cell Division, Cell Line, Transformed, Electrophoresis, Glycoproteins, Humans, Molecular Sequence Data, Phosphorylation, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Tumor Cells, Cultured, Blotting, Western, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases, Neuregulins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells. https://app.cochat.ai/papers/10.1016/0092-8674(92)90131-u
- The paper
- Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B., & Yarden, Y. (1992). Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell. https://doi.org/10.1016/0092-8674(92)90131-u
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.